Description

5-Hexenoic Acid, 6-(4-(2-(((4-Chlorophenyl)Sulfonyl)Amino)Ethyl)Phenyl )-6-(3-Pyridinyl)-, Compd. With Cyclohexanamine (2:1) is a high-purity, non-racemic chiral compound designed for advanced chemical synthesis. This product is critical for researchers and manufacturers requiring a sophisticated building block with specific stereochemistry for the development of novel active pharmaceutical ingredients (APIs) and fine chemicals. It is primarily utilized in pharmaceutical R&D, agrochemical synthesis, and as a key intermediate in the production of complex organic molecules.

Application

• Pharmaceutical Intermediate: Serves as a crucial chiral building block in the synthesis of novel drug candidates and active pharmaceutical ingredients (APIs).
• Agrochemical Research: Used in the development of advanced pesticides and herbicides requiring specific stereochemical configurations for efficacy.
• Fine Chemical Synthesis: Acts as a key intermediate for producing complex, high-value specialty chemicals and ligands.
• Asymmetric Catalysis: Employed in the research and development of chiral catalysts and auxiliaries.
• Academic & Industrial R&D: Essential for chemical research in universities and corporate labs focusing on organic methodology and new compound discovery.
• Material Science Precursor: Potential use in the synthesis of specialized polymers or advanced organic materials.

Basic Information

Item	Details
Product Name	5-Hexenoic Acid, 6-(4-(2-(((4-Chlorophenyl)Sulfonyl)Amino)Ethyl)Phenyl )-6-(3-Pyridinyl)-, Compd. With Cyclohexanamine (2:1)
CAS No.	133276-53-6
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	6-(4-(2-(((4-Chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(pyridin-3-yl)hex-5-enoic acid - cyclohexanamine (2:1); (R)-6-(4-(2-(((4-Chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(pyridin-3-yl)hex-5-enoic acid cyclohexanamine salt; Levamlodipine Besylate Intermediate; Amlodipine Besylate Related Compound; Chiral Amlodipine Intermediate; 5-Hexenoic acid, 6-[4-[2-[[(4-chlorophenyl)sulfonyl]amino]ethyl]phenyl]-6-(3-pyridinyl)-, (αR)-, compd. with cyclohexanamine (2:1); 133276-53-6.
EINECS	Contact for details

Quality Control

Our 5-Hexenoic Acid, 6-(4-(2-(((4-Chlorophenyl)Sulfonyl)Amino)Ethyl)Phenyl )-6-(3-Pyridinyl)-, Compd. With Cyclohexanamine (2:1) is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing, including chiral purity (enantiomeric excess) and chemical purity analysis, to ensure it meets the exacting standards required for pharmaceutical development. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and compliance with your research or cGMP guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture. Keep away from heat and incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Enantiomeric Excess (Chiral HPLC)	≥ 99.0%
Single Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 1.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.